B
L. E. Bermudez, Kolonoski, P., and Young, L. S.,
“Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor.”,
Lymphokine research, vol. 9, no. 2, pp. 137-45, 1990.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S.,
“Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”,
Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. E. Bermudez,
“Immunobiology of Mycobacterium avium infection.”,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13, no. 11, pp. 1000-6, 1994.
L. E. Bermudez, Sangari, F. J., Kolonoski, P., Petrofsky, M., and Goodman, J.,
“The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells.”,
Infection and immunity, vol. 70, no. 1, pp. 140-6, 2002.
L. E. Bermudez, Danelishvili, L., Babrack, L., and Pham, T.,
“Evidence for genes associated with the ability of Mycobacterium avium subsp. hominissuis to escape apoptotic macrophages.”,
Front Cell Infect Microbiol, vol. 5, p. 63, 2015.
L. E. Bermudez, Petrofsky, M., and Goodman, J.,
“Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.”,
Infection and immunity, vol. 65, no. 9, pp. 3768-73, 1997.
L. E. Bermudez, Kemper, C. A., and Deresinski, S. C.,
“Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF.”,
Biotherapy (Dordrecht, Netherlands), vol. 8, no. 2, pp. 135-42, 1994.
L. E. Bermudez and Young, L. S.,
“Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages.”,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 20, no. 2, pp. 191-201, 1987.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L., and Young, L. S.,
“Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 40, no. 3, pp. 546-51, 1996.
L. E. Bermudez, Goodman, J., and Petrofsky, M.,
“Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.”,
Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.
L. E. Bermudez, Shelton, K., and Young, L. S.,
“Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells.”,
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 76, no. 3, pp. 240-7, 1995.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S.,
“Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.”,
Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.
L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S.,
“Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”,
Cytokine, vol. 2, no. 4, pp. 287-93, 1990.
L. E. Bermudez, Petrofsky, M., and Stevens, P.,
“Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”,
Immunology, vol. 94, no. 3, pp. 297-303, 1998.
L. E. Bermudez and Young, L. S.,
“Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.”,
Journal of immunology (Baltimore, Md. : 1950), vol. 140, no. 9, pp. 3006-13, 1988.
L. E. Bermudez, Covaro, G., and Remington, J.,
“Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.”,
Infection and immunity, vol. 61, no. 10, pp. 4126-30, 1993.
L. E. Bermudez, Panza, M., Velasco, E., and Vidal, E.,
“[Effect of systemic antibiotic therapy on microbial flora of gastrointestinal tract in the hematological patients].”,
Revista paulista de medicina, vol. 102, no. 6, pp. 256-9, 1984.
L. E. Bermudez, Inderlied, C., and Young, L. S.,
“Stimulation with cytokines enhances penetration of azithromycin into human macrophages.”,
Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B.,
“Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
OREGON STATE UNIVERSITY
Open search box
]